Atnaujinkite slapukų nuostatas

El. knyga: Migraine

(Professor, Department of Neuology, Mayo Clinic), (Professor, Department of Neurology, Thomas Jefferson University Director, Jefferson Headache Center, Department of Neurology, Thomas Jefferson University Hospitals)
  • Formatas: PDF+DRM
  • Serija: Contemporary Neurology Series
  • Išleidimo metai: 16-Mar-2016
  • Leidėjas: Oxford University Press Inc
  • Kalba: eng
  • ISBN-13: 9780199793693
  • Formatas: PDF+DRM
  • Serija: Contemporary Neurology Series
  • Išleidimo metai: 16-Mar-2016
  • Leidėjas: Oxford University Press Inc
  • Kalba: eng
  • ISBN-13: 9780199793693

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Migraine is a complex neurological disorder that is characterized by a complex neurobiology, clinical features that may overlap with over 300 causes of headache, and an association with major medical illnesses and comorbid diseases. This books draws upon the authors' vast clinical experience and exhaustive knowledge of the science of migraine and the practice of headache medicine and provides this knowledge in a comprehensive yet digestible format. While migraine is often a subject in other textbooks on headache, it is the sole focus of this volume. The authors provide an up-to-date overview of the evidence base and combine this with their experience and expertise to help practitioners make informed treatment decisions. This book also provides a glimpse into the future describing new treatment modalities, including neurostimulation technologies and biologics that are emerging as potentially valuable treatment options. The authors also deal extensively with the unique and complex management of migraine in women throughout the reproductive life cycle. For those looking for a practical, insightful, and in-depth review on the subject of migraine, there is no other option.

Recenzijos

An excellent read not only for neurologists, but all clinicians that may come in contact with migraine sufferers. It may serve as a useful introduction, one can return to time and time again. * Christin Bird, The Australian Pain Society Newsletter *

1 Migraine Symptoms And Diagnosis 1(26)
Introduction
1(1)
Phases And Clinical Features Of Migraine
1(15)
Premonitory Phase (Prodrome)
Aura
Headache
Associated Phenomena
Common Non-ICHD Symptoms
Postdrome
The Classification Of Migraine
16(11)
Migraine without Aura
Migraine with Aura
Migraine Aura Without Headache
Chronic Migraine
Complications of Migraine
Migraine Aura-Triggered Seizure
Episodic Syndromes That May Be Associated with Migraine
Migraine Diagnosis Using ID Migraine™
2 Migraine Genetics 27(20)
Introduction
27(1)
The Genome
28(1)
The Chromosome
29(2)
Epigenetics
31(1)
Non-Coding RNA (NCRNA)
31(2)
Implications For Migraine Research
33(1)
Migraine Genetics
34(3)
Familial Hemiplegic Migraine: A Monogenic Migraine Subtype
Genes for Common Migraine Subtypes
Migraine Genome-Wide Association Studies
37(3)
Other Migraine Genes
Migraine and Genetic Vasculopathies
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy
40(1)
Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
41(1)
Hereditary Systemic Angiopathy
41(1)
COL4A1-Related Disorder
42(1)
References
42(5)
3 Less Common Migraine Subtypes 47(16)
Probable Migraine
47(1)
Hemiplegic Migraine
48(2)
Migraine With Brainstem Aura
50(2)
Retinal Migraine
52(1)
Visual Snow
53(1)
Vestibular Migraine
54(3)
Epilepsy And Migraine
57(1)
References
58(5)
4 Migraine Comorbidity 63(22)
Migraine, Cardiovascular, And Cerebrovascular Disease
65(1)
Pregnancy-Related Hypertension
66(1)
Coronary Heart Disease
67(1)
Congenital Heart Defects
68(1)
Epilepsy
69(1)
Psychiatric Comorbidity
70(2)
Pain
72(2)
Obesity
74(1)
Allergy
75(1)
Association Between Restless Legs Syndrome And Migraine
76(2)
Migraine, Raynaud's Syndrome, And Other Rheumatologic Disorders
78(1)
References
78(7)
5 Migraine Pathogenesis 85(38)
Introduction
85(1)
Pathophysiology
86(11)
Anatomy of Cephalic Pain
Headache
Does Migraine Headache Result from Vasodilation?
Sensitization In Migraine
97(4)
Peripheral Sensitization
Central Sensitization
Does Sensitization Play a Role in Headache?
Pain Modulation
101(2)
Neuroimaging
103(2)
The Aura And Headache
105(6)
What Could Initiate Activation of Trigeminovascular Afferents in the Absence of a Clinical Aura?
Associated Symptoms Of Migraine
111(3)
Photophobia
Phonophobia
Nausea/Emesis
Conclusion
114(1)
References
114(9)
6 Non-Pharmacologic Therapy 123(12)
Relaxation Training
125(1)
Cognitive Behavioral Therapy
125(1)
Biofeedback
126(1)
Behavioral Treatment Approaches
126(1)
Efficacy Of Behavioral Treatments
126(1)
Limited And No-Contact Behavioral Interventions
127(1)
Telephone-Administered Treatment
127(1)
Internet- And Mass Media—administered Treatment
128(1)
Mindfulness-Based Stress Reduction
128(1)
Exercise
128(1)
Combining Behavioral And Drug Therapy
129(1)
Comorbid Mood Disorders
130(1)
Older Adults
130(1)
Children And Adolescents
131(1)
School-Based Behavioral Interventions
131(1)
Pregnancy
131(1)
References
132(3)
7 Acute Migraine Therapy 135(28)
Introduction
135(1)
General Principles
136(2)
Acute Treatment Strategy
Timing of Administration
Formulation
Use of Adjunctive Medications
Rescue Therapy
Avoid Acute Medication Overuse
Acute Medications
138(6)
Migraine Specific Medications
Other Migraine-Specific Medications
Non-Specific Medications
144(6)
Simple Analgesics and NSAIDs
Opioids
Butalbital-Containing Products
Neuroleptics (Dopamine Antagonists)
Acute Treatment Guidelines
150(1)
Emerging Acute Therapies
151(2)
5-HT 1F Receptor Antagonists
153(1)
CGRP Receptor Antagonists
154(1)
References
155(8)
8 Preventive Treatment 163(30)
Introduction
163(1)
Impact Of Preventive Treatment
164(1)
Principles Of Preventive Treatment
164(1)
General Principles For Instituting Preventive Therapy
165(1)
Guidelines For Stopping Preventive Therapy
166(1)
Specific Migraine Preventive Agents
167(9)
β-Adrenergic Blockers for the Prevention of Migraine
Antidepressant Medication for Migraine Prevention
Calcium Channel Antagonists for the Prevention of Migraine
Anti-epileptic Drugs for the Prevention of Migraine
Serotonin Antagonists
176(1)
Methysergide
Cyproheptadine
Other Drugs For The Prevention Of Migraine
176(2)
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists
NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults
Medicinal Herbs, Vitamins, And Other Interventions
178(2)
Herbal Preparations, Vitamins, and Minerals
Aspirin and Other NSAIDS
New Preventive Medications
180(1)
CGRP Antibody Antagonists[ 137]
Botulinum Toxin For Migraine
181(5)
Formulations of Botulinum Toxin
Mechanism of Action of Botulinum Toxin in Headache
BoNT Treatment Techniques
Clinical Studies of BoNT's Efficacy in Headache Disorders
Adverse Events Associated with the Use of BoNT
Appendix 1: AAN Classification Of Evidence For The Rating Of A Therapeutic Study
186(1)
Appendix 2: Classification Of Recommendations
187(1)
References
187(6)
9 Chronic Migraine 193(50)
Introduction
193(2)
The History Of CM/TM Classification
195(1)
ICHD-1 (1988)
195(2)
Silberstein-Lipton Criteria (1994, 1996)
197(1)
ICHD-2 (2004)
198(1)
ICHD-2R (2006)
199(3)
ICHD-3 (Beta [ P] Version)
202(1)
Recommendations For Diagnostic Criteria For CM/TM
202(4)
Differentiating CM from Other Chronic Daily Headaches
Medication Overuse Headache (MOH)
206(4)
Definition and Classification of MOH
Clinical Features of MOH
Psychiatric Comorbidity Of CM
210(2)
Other Comorbidities
212(1)
Epidemiology Of CDH And CM
213(4)
Risk Factors for CDH
Pathophysiology Of CM
217(1)
Treatment
218(13)
Overview
Acute Pharmacotherapy
Preventive Pharmacotherapy
Antidepressants
Anti-epileptic Drugs
Neurotoxins
Treatment with Limited Supporting Evidence
Other Medications
Opioid Maintenance
Non-pharmacological Treatment
Breaking the Headache Cycle
Strategies of Treatment
Prognosis
231(4)
Why Treatment Fails
Prevention
235(1)
References
235(8)
10 Neuromodulation 243(16)
Peripheral Nerve Stimulation
243(8)
Occipital Nerve Stimulation
Sphenopalatine Ganglion Stimulation
Supraorbital Nerve Stimulation
Vagal Nerve Stimulation
Central Neurostimulation
251(3)
Single-Pulse Transcranial Magnetic Stimulation
Repetitive Transcranial Magnetic Stimulation (rTMS)
Transcranial Direct Current Stimulation (tDCS)
References
254(5)
11 Hormones 259(38)
Introduction
259(1)
Menstruation And Migraine
260(3)
Treatment Of Headaches Associated With The Menstrual Cycle
263(1)
Overview
Acute Treatment
Preventive Treatment
263(6)
Migraine Associated With Hormonal Contraceptive Use
269(6)
Introduction
Transdermal Contraceptive Patch
Vaginal Rings
Injectable and Implantable Hormonal Contraception
Adverse Events
275(12)
Contraceptive Use
References
287(10)
Index 297
David W. Dodick: Professor of Neurology Mayo Clinic in Phoenix Arizona, Director Headache Division, Director Sport Neurology Division, Director Neurology Residency Program, Director Headache Fellowship Program, President-Elect International Headache Society, Chair American Migraine Foundation, Past-President American Headache Society, Editor-in-Chief, Cephalalgia (official journal of the International Headache Society) Stephen Silberstein: Dr. Michael Silverstein is the Director of the Division of General Pediatrics and an Associate Professor of Pediatrics at BUSM, as well as the Vice Chairman for Research for the Department of Pediatrics. He attended Harvard University and Harvard Medical School and completed his medical training at the University of Washington, where he also did his fellowship in the Robert Wood Johnson Clinical Scholars Program. He joined the Boston University faculty in 2004.